- Filed
- Feb 11, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2026 · Feb 8, 2026 | 18.05M sh |
| Shares Diluted | Q2 2026 · Dec 31, 2025 | 17.88M sh |
| Shares Diluted | Q2 2026 · Dec 31, 2025 | 17.01M sh |
| Shares Diluted | Q2 2026 · Dec 31, 2024 | 12.21M sh |
| Shares Diluted | Q2 2026 · Dec 31, 2024 | 12.2M sh |
| Capex | Q2 2026 · Dec 31, 2025 | $241K |
| Capex restated | Q2 2026 · Dec 31, 2024 | $41K |
| Operating Cash Flow | Q2 2026 · Dec 31, 2025 | −$1.07M |
| Operating Cash Flow restated | Q2 2026 · Dec 31, 2024 | −$1.33M |
| Cash And Equivalents | Q2 2026 · Dec 31, 2025 | $38.57M |
| Cash And Equivalents | Q2 2026 · Jun 30, 2025 | $3.63M |
| Stockholders Equity | Q2 2026 · Dec 31, 2025 | $40.8M |
| Stockholders Equity | Q2 2026 · Sep 30, 2025 | $40.89M |
| Stockholders Equity | Q2 2026 · Jun 30, 2025 | $17.9M |
| Stockholders Equity restated | Q2 2026 · Dec 31, 2024 | $1.03M |
| Stockholders Equity restated | Q2 2026 · Sep 30, 2024 | $1.71M |
| Stockholders Equity restated | Q2 2026 · Jun 30, 2024 | $2.28M |
| Current Liabilities | Q2 2026 · Dec 31, 2025 | $825K |
| Current Liabilities | Q2 2026 · Jun 30, 2025 | $705K |
| Total Liabilities | Q2 2026 · Dec 31, 2025 | $1.77M |
| Total Liabilities | Q2 2026 · Jun 30, 2025 | $1.51M |
| Current Assets | Q2 2026 · Dec 31, 2025 | $40.26M |
| Current Assets | Q2 2026 · Jun 30, 2025 | $17.34M |
| Total Assets | Q2 2026 · Dec 31, 2025 | $42.57M |
| Total Assets | Q2 2026 · Jun 30, 2025 | $19.41M |
| Eps Diluted | Q2 2026 · Dec 31, 2025 | −$0.11 |
| Eps Diluted | Q2 2026 · Dec 31, 2025 | −$0.20 |
| Eps Diluted | Q2 2026 · Dec 31, 2024 | −$0.24 |
| Eps Diluted | Q2 2026 · Dec 31, 2024 | −$0.30 |
| Eps Basic | Q2 2026 · Dec 31, 2025 | −$0.11 |
| Eps Basic | Q2 2026 · Dec 31, 2025 | −$0.20 |
| Eps Basic | Q2 2026 · Dec 31, 2024 | −$0.24 |
| Eps Basic | Q2 2026 · Dec 31, 2024 | −$0.30 |
| Sga Expense | Q2 2026 · Dec 31, 2025 | $1.53M |
| Sga Expense | Q2 2026 · Dec 31, 2025 | $3.21M |
| Sga Expense restated | Q2 2026 · Dec 31, 2024 | $371K |
| Sga Expense restated | Q2 2026 · Dec 31, 2024 | $867K |
| Rd Expense | Q2 2026 · Dec 31, 2025 | $906K |
| Rd Expense | Q2 2026 · Dec 31, 2025 | $1.51M |
| Rd Expense restated | Q2 2026 · Dec 31, 2024 | $268K |
| Rd Expense restated | Q2 2026 · Dec 31, 2024 | $669K |
| Net Income | Q2 2026 · Dec 31, 2025 | −$1.85M |
| Net Income | Q2 2026 · Dec 31, 2025 | −$3.35M |
| Net Income restated | Q2 2026 · Dec 31, 2024 | −$2.9M |
| Net Income restated | Q2 2026 · Dec 31, 2024 | −$3.63M |
| Operating Income | Q2 2026 · Dec 31, 2025 | −$2.08M |
| Operating Income | Q2 2026 · Dec 31, 2025 | −$3.69M |
| Operating Income restated | Q2 2026 · Dec 31, 2024 | $389K |
| Operating Income restated | Q2 2026 · Dec 31, 2024 | −$342K |
| Cost Of Revenue | Q2 2026 · Dec 31, 2025 | $919K |
| Cost Of Revenue | Q2 2026 · Dec 31, 2025 | $1.62M |
| Cost Of Revenue restated | Q2 2026 · Dec 31, 2024 | $584K |
| Cost Of Revenue restated | Q2 2026 · Dec 31, 2024 | $899K |
| Revenue | Q2 2026 · Dec 31, 2025 | $1.27M |
| Revenue | Q2 2026 · Dec 31, 2025 | $2.66M |
| Revenue restated | Q2 2026 · Dec 31, 2024 | $1.61M |
| Revenue restated | Q2 2026 · Dec 31, 2024 | $2.09M |
| Short Term Debt | Q2 2026 · Aug 31, 2024 | $3.1M |